Tenet Provides Corporate Update Following Annual Meeting of Shareholders
Toronto, Ontario–(Newsfile Corp. – June 29, 2023) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
Toronto, Ontario–(Newsfile Corp. – June 29, 2023) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
Ucore has recently acquired more than 2 tonnes of a mixed light rare earth element…
Arlington, Virginia–(Newsfile Corp. – June 29, 2023) – The National Electrical Manufacturers Association (NEMA) and…
HONG KONG, Jun 29, 2023 – (ACN Newswire) – Tat Hong Equipment Service Co., Ltd….
HONG KONG, Jun 29, 2023 – (ACN Newswire) – AEON Credit Service (Asia) Company Limited…
HONG KONG, Jun 29, 2023 – (ACN Newswire) – Regina Miracle International (Holdings) Limited (“Regina…
New Sales Intelligence APIs and UIs deliver auto-generated, context-aware call scores, summaries and conversation insights…
OneStream earned best-in-class for robustness, completeness, reliability of technology; and named an overall leader for…
SAN JOSE, Calif.–(BUSINESS WIRE)–#esg—MetricStream, the global market leader in integrated risk management (IRM) and governance,…
Cullie to advance the water industry through innovative technology aimed at enhancing the customer experience…
SAN FRANCISCO, June 29, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
SAN FRANCISCO, June 29, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
Curia recognized for providing a best-in-class customer experience in the CRDMO industry through its innovative…
Curia recognized for providing a best-in-class customer experience in the CRDMO industry through its innovative…
– EVLO common stock expected to begin trading on a split-adjusted basis on June 30,…
– EVLO common stock expected to begin trading on a split-adjusted basis on June 30,…
Submitted NDA for Libervant™ (diazepam) Buccal Film for treatment of seizure clusters in patients between…
Submitted NDA for Libervant™ (diazepam) Buccal Film for treatment of seizure clusters in patients between…
– Patient dosing initiated in LUMUS, a 388 patient Phase 2b clinical trial of ESK-001…
– Patient dosing initiated in LUMUS, a 388 patient Phase 2b clinical trial of ESK-001…